Barclays’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $734M | Sell |
1,592,310
-642,570
| -29% | -$325M | 0.18% | 86 |
|
|
2025
Q4 | $1.27B | Buy |
2,234,880
+232,993
| +12% | +$124M | 0.3% | 36 |
|
|
2025
Q3 | $895M | Buy |
2,001,887
+252,052
| +14% | +$121M | 0.19% | 68 |
|
|
2025
Q2 | $951M | Buy |
1,749,835
+11,696
| +0.7% | +$6.12M | 0.22% | 53 |
|
|
2025
Q1 | $861M | Buy |
1,738,139
+238,677
| +16% | +$132M | 0.24% | 55 |
|
|
2024
Q4 | $783M | Buy |
1,499,462
+114,517
| +8% | +$59.6M | 0.22% | 50 |
|
|
2024
Q3 | $680M | Buy |
1,384,945
+1,303
| +0.1% | +$607K | 0.18% | 76 |
|
|
2024
Q2 | $616M | Sell |
1,383,642
-89,668
| -6% | -$35.7M | 0.19% | 73 |
|
|
2024
Q1 | $588M | Buy |
1,473,310
+118,412
| +9% | +$44.7M | 0.2% | 88 |
|
|
2023
Q4 | $457M | Buy |
1,354,898
+324,846
| +32% | +$96.8M | 0.17% | 101 |
|
|
2023
Q3 | $301M | Sell |
1,030,052
-349,194
| -25% | -$109M | 0.19% | 109 |
|
|
2023
Q2 | $472M | Buy |
1,379,246
+892,651
| +183% | +$270M | 0.3% | 68 |
|
|
2023
Q1 | $124M | Sell |
486,595
-399,061
| -45% | -$98.3M | 0.06% | 221 |
|
|
2022
Q4 | $235M | Buy |
885,656
+271,266
| +44% | +$66.1M | 0.11% | 148 |
|
|
2022
Q3 | $115M | Buy |
614,390
+70,490
| +13% | +$15.1M | 0.13% | 159 |
|
|
2022
Q2 | $109M | Sell |
543,900
-167,988
| -24% | -$39.4M | 0.07% | 208 |
|
|
2022
Q1 | $215M | Sell |
711,888
-366,966
| -34% | -$107M | 0.17% | 124 |
|
|
2021
Q4 | $388M | Buy |
1,078,854
+196,674
| +22% | +$67.7M | 0.14% | 119 |
|
|
2021
Q3 | $292M | Buy |
882,180
+296,922
| +51% | +$99.7M | 0.13% | 122 |
|
|
2021
Q2 | $179M | Buy |
585,258
+69,729
| +14% | +$19.6M | 0.08% | 190 |
|
|
2021
Q1 | $127M | Buy |
515,529
+113,055
| +28% | +$28.4M | 0.07% | 218 |
|
|
2020
Q4 | $110M | Buy |
402,474
+74,721
| +23% | +$18.6M | 0.06% | 249 |
|
|
2020
Q3 | $77.5M | Buy |
327,753
+14,811
| +5% | +$3.33M | 0.05% | 280 |
|
|
2020
Q2 | $59.4M | Buy |
312,942
+38,754
| +14% | +$6.95M | 0.05% | 301 |
|
|
2020
Q1 | $45.3M | Sell |
274,188
-281,985
| -51% | -$51.6M | 0.04% | 337 |
|
|
2019
Q4 | $110M | Sell |
556,173
-94,572
| -15% | -$17.7M | 0.06% | 248 |
|
|
2019
Q3 | $117M | Buy |
650,745
+127,131
| +24% | +$22M | 0.07% | 209 |
|
|
2019
Q2 | $91.6M | Buy |
523,614
+143,649
| +38% | +$24.6M | 0.06% | 293 |
|
|
2019
Q1 | $72.3M | Buy |
379,965
+31,746
| +9% | +$5.64M | 0.05% | 332 |
|
|
2018
Q4 | $55.6M | Sell |
348,219
-190,140
| -35% | -$32.2M | 0.04% | 348 |
|
|
2018
Q3 | $103M | Buy |
538,359
+128,859
| +31% | +$22.9M | 0.07% | 203 |
|
|
2018
Q2 | $65.3M | Sell |
409,500
-224,037
| -35% | -$34.2M | 0.06% | 288 |
|
|
2018
Q1 | $87.2M | Sell |
633,537
-242,346
| -28% | -$33.8M | 0.07% | 243 |
|
|
2017
Q4 | $107M | Buy |
875,883
+392,466
| +81% | +$49.1M | 0.09% | 188 |
|
|
2017
Q3 | $56.2M | Buy |
483,417
+98,667
| +26% | +$10.8M | 0.06% | 265 |
|
|
2017
Q2 | $40M | Buy |
384,750
+205,785
| +115% | +$19.8M | 0.04% | 348 |
|
|
2017
Q1 | $15.2M | Sell |
178,965
-14,724
| -8% | -$1.16M | 0.02% | 669 |
|
|
2016
Q4 | $13.6M | Sell |
193,689
-87,633
| -31% | -$6.44M | 0.01% | 794 |
|
|
2016
Q3 | $22.7M | Buy |
281,322
+125,352
| +80% | +$9.6M | 0.03% | 494 |
|
|
2016
Q2 | $11.5M | Sell |
155,970
-105,777
| -40% | -$7.44M | 0.01% | 772 |
|
|
2016
Q1 | $17.5M | Buy |
261,747
+54,801
| +26% | +$3.4M | 0.03% | 524 |
|
|
2015
Q4 | $12.6M | Buy |
206,946
+6,552
| +3% | +$368K | 0.02% | 777 |
|
|
2015
Q3 | $10.2M | Sell |
200,394
-11,394
| -5% | -$645K | 0.01% | 924 |
|
|
2015
Q2 | $11.4M | Sell |
211,788
-55,017
| -21% | -$3.08M | 0.01% | 954 |
|
|
2015
Q1 | $15M | Sell |
266,805
-55,971
| -17% | -$3.17M | 0.02% | 845 |
|
|
2014
Q4 | $18.9M | Sell |
322,776
-208,989
| -39% | -$11.6M | 0.02% | 795 |
|
|
2014
Q3 | $27.2M | Buy |
531,765
+205,254
| +63% | +$10.2M | 0.03% | 568 |
|
|
2014
Q2 | $14.9M | Sell |
326,511
-431,559
| -57% | -$19M | 0.02% | 882 |
|
|
2014
Q1 | $36.8M | Buy |
758,070
+140,481
| +23% | +$6.62M | 0.04% | 395 |
|
|
2013
Q4 | $26.3M | Buy |
617,589
+99,306
| +19% | +$4.18M | 0.03% | 610 |
|
|
2013
Q3 | $21.7M | Buy |
518,283
+179,973
| +53% | +$7.95M | 0.03% | 628 |
|
|
2013
Q2 | $19M | Buy |
+338,310
| New | +$18.6M | 0.02% | 667 |
|
Other funds holding ISRG
VCM
VPM
Barclays's ISRG Position: Q1 2026 in Review
Barclays reduced its Intuitive Surgical (ISRG) stake by 29% in Q1 2026, selling an estimated $325M and leaving 1,592,310 shares worth $734M. The position accounts for 0.18% of the portfolio, ranked #86.
Barclays first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.27B in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Barclays held 1,592,310 shares of Intuitive Surgical worth $734M as of Q1 2026.
- Barclays sold 642,570 Intuitive Surgical shares in Q1 2026, an estimated $325M.
- Intuitive Surgical made up 0.18% of Barclays's portfolio in Q1 2026, its #86 holding.
- Barclays first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
- Barclays's Intuitive Surgical position peaked at $1.27B in Q4 2025.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.